Irma Dianzani
Overview
Explore the profile of Irma Dianzani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1880
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aspesi A, La Vecchia M, Sala G, Ghelardi E, Dianzani I
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769073
An increasingly important role for gut microbiota in the initiation and progression of colorectal cancer (CRC) has been described. Even in the early stages of transformation, i.e., colorectal adenomas, changes...
2.
La Vecchia M, Sala G, Sculco M, Aspesi A, Dianzani I
Clin Exp Med
. 2024 Oct;
24(1):248.
PMID: 39470880
Colorectal cancer (CRC) ranks among the most prevalent malignant tumors worldwide, with a multifactorial etiology encompassing genetic, environmental, and life-style factors, as well as the intestinal microbiota and its metabolome....
3.
Wlodarski M, Vlachos A, Farrar J, Da Costa L, Kattamis A, Dianzani I, et al.
Lancet Haematol
. 2024 May;
11(5):e368-e382.
PMID: 38697731
Diamond-Blackfan anaemia (DBA), first described over 80 years ago, is a congenital disorder of erythropoiesis with a predilection for birth defects and cancer. Despite scientific advances, this chronic, debilitating, and...
4.
Rossi G, Righi L, Barbisan F, Tiseo M, Spagnolo P, Grosso F, et al.
J Pers Med
. 2024 Apr;
14(4).
PMID: 38673021
The pathologic diagnosis of pleural mesothelioma is generally based on international guidelines, but no compulsory points based on different drugs approvals in different European countries are required to be reported....
5.
Clavenna M, La Vecchia M, Sculco M, Joseph S, Barberis E, Amede E, et al.
Cancers (Basel)
. 2023 Jun;
15(12).
PMID: 37370676
According to the driver-passenger model for colorectal cancer (CRC), the tumor-associated microbiota is a dynamic ecosystem of bacterial species where bacteria with carcinogenic features linked to CRC initiation are defined...
6.
Casalone E, Birolo G, Pardini B, Allione A, Russo A, Catalano C, et al.
Cancers (Basel)
. 2023 Jan;
15(1).
PMID: 36612122
Malignant pleural mesothelioma (MPM) is an aggressive cancer with a dismal prognosis. Early therapeutic interventions could improve patient outcomes. We aimed to identify a pattern of microRNAs (miRNAs) as potential...
7.
Piantanida N, La Vecchia M, Sculco M, Talmon M, Palattella G, Kurita R, et al.
Front Genet
. 2022 Dec;
13:1045236.
PMID: 36579335
Diamond Blackfan anemia (DBA) is a rare congenital disease characterized by defective maturation of the erythroid progenitors in the bone marrow, for which treatment involves steroids, chronic transfusions, or hematopoietic...
8.
Diagnostics of -Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience
Sculco M, La Vecchia M, Aspesi A, Clavenna M, Salvo M, Borgonovi G, et al.
Diagnostics (Basel)
. 2022 Jul;
12(7).
PMID: 35885614
Germline mutations in the tumor suppressor gene BRCA1-associated protein-1 () lead to tumor predisposition syndrome (-TPDS), characterized by high susceptibility to several tumor types, chiefly melanoma, mesothelioma, renal cell carcinoma,...
9.
Carbone M, Pass H, Ak G, Alexander Jr H, Baas P, Baumann F, et al.
J Thorac Oncol
. 2022 Apr;
17(7):873-889.
PMID: 35462085
The most common malignancies that develop in carriers of BAP1 germline mutations include diffuse malignant mesothelioma, uveal and cutaneous melanoma, renal cell carcinoma, and less frequently, breast cancer, several types...
10.
Sculco M, La Vecchia M, Aspesi A, Pinton G, Clavenna M, Casalone E, et al.
Eur J Cancer
. 2022 Jan;
163:44-54.
PMID: 35032816
Introduction: Malignant pleural mesothelioma (MPM) is a tumour associated with asbestos exposure. Approximately, 10% of patients with MPM carry a germline pathogenic variant (PV), mostly in DNA repair genes, suggesting...